Emergency Department Patients’ Perspectives on Being Offered HIV Pre-Exposure Prophylaxis (PrEP) Services in an Urban ED

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported in part through the computational and data resources and staff expertise provided by Scientific Computing and Data at the Icahn School of Medicine at Mount Sinai and supported by the Clinical and Translational Science Awards (CTSA) grant UL1TR004419 from the National Center for Advancing Translational Sciences. Grant funding: -National Institute of Mental Health P30MH043520-33S2 (HIV Center Administrative Supplement. Designing Differentiated PrEP Service Delivery Models for Implementation in New York City Emergency Departments through a Community Collaborative (PI: Robert H. Remien, PhD; Supplement PD: Susie Hoffman, DrPH) -National Institute of Mental Health K23MH136923-01 (PI: Rachel Solnick, MD MSc) 

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

. The study was approved by the Institutional Review Boards (IRBs) of the Albert Einstein College of Medicine-Montefiore Medical Center (IRB #2021-13676), the Mount Sinai Health System (STUDY-21-01811), and the New York State Psychiatric Institute/Columbia University Department of Psychiatry (IRB #8239).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes